For the first time ever Photonics presented an engineering prototype of stLase laser system for soft tissues surgery at Photonica-2012

Last week, on April 17-20, Photonics, Ltd. financed by Maxwell Biotech Venture Fund, created with the participation of RVC, and RVC Seed Fund, took part in laser equipment fair “PHOTONICA. The world of laser and optics – 2012”. The Company presented stLase, an innovative laser system designated for soft tissues surgery. The showpiece presented at the Company’s stand was one of 5 devices produced at the beginning of 2012.

“PHOTONICA. The world of laser and optics” fair, which is held annually in Expocenter, is the most recognized and competent platform for demonstration of achievements in the field of laser techniques, optics and electro optics. It gathers respectable target audience, including not only technical specialists and professionals, but also consumers and users of the developed equipment. This year the fair presented 149 participating companies from 12 countries (Russia, USA, Germany, France, China, etc.) and was visited by around 8,000 people.

At the fair, technical specialists, who are engaged in laser technologies, as well as practicing general practitioners and dentists got acquainted with stLase and paid attention to its core advantages: compatibility, multifunctionality, usability as well as its relatively low costs. Spheres of application of the equipment, developed by Photonics, are dentistry, non-contact cardiovascular surgery, surgical interference in obstetrics and gynecology, otolaryngology, proctology, and other medical spheres.

Dmitry Popov, managing partner of Maxwell Biotech Venture Fund: “It is really very important for our fund that the product, developed by Photonics, was interesting for  both specialists and potential consumers. As soon as the registration procedures are completed, we are planning to embark on active promotion of stLase to medical equipment marker in Russia and the CIS countries”.

Photo: Photonics stand at PHOTONICA 2012



Anna Zelenkova,
PR director with Maxwell Biotech Group;
Tel.: +7 (495) 411-6992